Quarterly report pursuant to Section 13 or 15(d)

EQUITY TRANSACTIONS (Details Narrative)

v3.21.2
EQUITY TRANSACTIONS (Details Narrative) - USD ($)
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Common stock, par value     $ 0.001
Non-controlling interest, description The non-controlling interest presented in our condensed consolidated financial statements reflects a 46% non-controlling equity interest in PWS and 49% non-controlling equity interest in PelleChar.    
Short-Term Note Holders One [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Number of shares issued during the period   1,132,500  
Common stock, par value   $ 0.001  
Number of shares issued during the period, value   $ 125,400  
Short Term Note Holders [Member] | Origination Agreement [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Number of shares issued during the period   575,000  
Common stock, par value   $ 0.001  
Number of shares issued during the period, value   $ 60,500  
Short Term Note Holders [Member] | Extension Agreement [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Number of shares issued during the period   200,000  
Common stock, par value   $ 0.001  
Number of shares issued during the period, value   $ 20,000  
Short-Term Note Holders Two [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Common stock, par value   $ 0.001  
Number of shares issued options to purchase common stock   60,000  
Shares issued price per share   $ 0.10  
Shares based payments, volatility rate   134.00%  
Share based payment, risk-free rate   0.29%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term   3 years  
Share based payments, fair value at grant date   $ 3,500  
Short-Term Note Holders Three [Member]      
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]      
Common stock, par value   $ 0.001  
Number of shares issued options to purchase common stock   30,000  
Shares issued price per share   $ 0.10  
Shares based payments, volatility rate   134.00%  
Share based payment, risk-free rate   0.30%  
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term   3 years  
Share based payments, fair value at grant date   $ 2,000